196 related articles for article (PubMed ID: 16051111)
1. High atrial antitachycardia pacing therapy efficacy is associated with a reduction in atrial tachyarrhythmia burden in a subset of patients with sinus node dysfunction and paroxysmal atrial fibrillation.
Gillis AM; Koehler J; Morck M; Mehra R; Hettrick DA
Heart Rhythm; 2005 Aug; 2(8):791-6. PubMed ID: 16051111
[TBL] [Abstract][Full Text] [Related]
2. The effect of atrial pacing therapies on atrial tachyarrhythmia burden and frequency: results of a randomized trial in patients with bradycardia and atrial tachyarrhythmias.
Lee MA; Weachter R; Pollak S; Kremers MS; Naik AM; Silverman R; Tuzi J; Wang W; Johnson LJ; Euler DE;
J Am Coll Cardiol; 2003 Jun; 41(11):1926-32. PubMed ID: 12798559
[TBL] [Abstract][Full Text] [Related]
3. New-generation atrial antitachycardia pacing (Reactive ATP) is associated with reduced risk of persistent or permanent atrial fibrillation in patients with bradycardia: Results from the MINERVA randomized multicenter international trial.
Padeletti L; Pürerfellner H; Mont L; Tukkie R; Manolis AS; Ricci R; Inama G; Serra P; Scheffer MG; Martins V; Warman EN; Vimercati M; Grammatico A; Boriani G;
Heart Rhythm; 2015 Aug; 12(8):1717-25. PubMed ID: 25869753
[TBL] [Abstract][Full Text] [Related]
4. Clinical trials of pacing for maintenance of sinus rhythm.
Gillis AM
J Interv Card Electrophysiol; 2004; 10 Suppl 1():55-62. PubMed ID: 14739740
[TBL] [Abstract][Full Text] [Related]
5. [Effect of antitachycardia pacemaker on atrial tachyarrhythmia detection, prevention and termination].
Bai R; Wang TM; Lin L; Kam R; Wee St; Wang L
Zhonghua Xin Xue Guan Bing Za Zhi; 2006 Apr; 34(4):333-7. PubMed ID: 16776927
[TBL] [Abstract][Full Text] [Related]
6. Randomized comparison between Ramp and Burst+ atrial antitachycardia pacing therapies in patients suffering from sinus node disease and atrial fibrillation and implanted with a DDDRP device.
Gulizia M; Mangiameli S; Orazi S; Chiarandà G; Boriani G; Piccione G; DiGiovanni N; Colletti A; Puntrello C; Butera G; Vasco C; Vaccaro I; Scardace G; Grammatico A;
Europace; 2006 Jul; 8(7):465-73. PubMed ID: 16798758
[TBL] [Abstract][Full Text] [Related]
7. Right atrial preventive and antitachycardia pacing for prevention of paroxysmal atrial fibrillation in patients without bradycardia: a randomized study.
Hemels ME; Ruiter JH; Molhoek GP; Veeger NJ; Wiesfeld AC; Ranchor AV; van Trigt M; Pilmeyer A; Van Gelder IC; ;
Europace; 2008 Mar; 10(3):306-13. PubMed ID: 18245199
[TBL] [Abstract][Full Text] [Related]
8. Effects of long-term ω-3 polyunsaturated fatty acid supplementation on paroxysmal atrial tachyarrhythmia burden in patients with implanted pacemakers: results from a prospective randomised study.
Kumar S; Sutherland F; Stevenson I; Lee JM; Garg ML; Sparks PB
Int J Cardiol; 2013 Oct; 168(4):3812-7. PubMed ID: 23890856
[TBL] [Abstract][Full Text] [Related]
9. Ventricular high-rate episodes in pacemaker diagnostics identify a high-risk subgroup of patients with tachy-brady syndrome.
Willems R; Morck ML; Exner DV; Rose SM; Gillis AM
Heart Rhythm; 2004 Oct; 1(4):414-21. PubMed ID: 15851193
[TBL] [Abstract][Full Text] [Related]
10. Pace-termination and pacing for prevention of atrial tachyarrhythmias: results from a multicenter study with an implantable device for atrial therapy.
Israel CW; Hügl B; Unterberg C; Lawo T; Kennis I; Hettrick D; Hohnloser SH;
J Cardiovasc Electrophysiol; 2001 Oct; 12(10):1121-8. PubMed ID: 11699520
[TBL] [Abstract][Full Text] [Related]
11. Reduction of atrial tachyarrhythmia episodes during the overdrive pacing period using the post-mode switch overdrive pacing (PMOP) algorithm.
Pürerfellner H; Ruiter JH; Widdershoven JW; Van Gelder IC; Urban L; Kirchhof CJ; Havlicek A; Kornet L;
Heart Rhythm; 2006 Oct; 3(10):1164-71. PubMed ID: 17018345
[TBL] [Abstract][Full Text] [Related]
12. Pacing or ablation: which is better for paroxysmal atrial fibrillation-related tachycardia-bradycardia syndrome?
Chen YW; Bai R; Lin T; Salim M; Sang CH; Long DY; Yu RH; Tang RB; Guo XY; Yan XL; Nie JG; Du X; Dong JZ; Ma CS
Pacing Clin Electrophysiol; 2014 Apr; 37(4):403-11. PubMed ID: 24456243
[TBL] [Abstract][Full Text] [Related]
13. A controlled study on the effect of verapamil on atrial tachycaarrhythmias in patients with brady-tachy syndrome implanted with a DDDR pacemaker.
Boriani G; Bertaglia E; Carboni A; Latini R; Biffi M; Martignani C; Sciotto F; Branzi A
Int J Cardiol; 2005 Sep; 104(1):73-6. PubMed ID: 16137513
[TBL] [Abstract][Full Text] [Related]
14. Incremental programming of atrial anti-tachycardia pacing therapies in bradycardia-indicated patients: effects on therapy efficacy and atrial tachyarrhythmia burden.
Hügl B; Israel CW; Unterberg C; Lawo T; Geller JC; Kennis IM; Euler DE; Koehler JL; Hettrick DA;
Europace; 2003 Oct; 5(4):403-9. PubMed ID: 14753639
[TBL] [Abstract][Full Text] [Related]
15. Impact of atrial prevention pacing on atrial fibrillation burden: primary results of the Study of Atrial Fibrillation Reduction (SAFARI) trial.
Gold MR; Adler S; Fauchier L; Haffajee C; Ip J; Kainz W; Kawasaki R; Prakash A; Táborský M; Waller T; Wilson V; Li S; Hoffmann E;
Heart Rhythm; 2009 Mar; 6(3):295-301. PubMed ID: 19251200
[TBL] [Abstract][Full Text] [Related]
16. Combined efficacy of atrial septal lead placement and atrial pacing algorithms for prevention of paroxysmal atrial tachyarrhythmia.
Padeletti L; Pürerfellner H; Adler SW; Waller TJ; Harvey M; Horvitz L; Holbrook R; Kempen K; Mugglin A; Hettrick DA;
J Cardiovasc Electrophysiol; 2003 Nov; 14(11):1189-95. PubMed ID: 14678133
[TBL] [Abstract][Full Text] [Related]
17. Safety and efficacy of advanced atrial pacing therapies for atrial tachyarrhythmias in patients with a new implantable dual chamber cardioverter-defibrillator.
Gillis AM; Unterberg-Buchwald C; Schmidinger H; Massimo S; Wolfe K; Kavaney DJ; Otterness MF; Hohnloser SH;
J Am Coll Cardiol; 2002 Nov; 40(9):1653-9. PubMed ID: 12427419
[TBL] [Abstract][Full Text] [Related]
18. The use of atrial overdrive and ventricular rate stabilization pacing algorithms for the prevention and treatment of paroxysmal atrial fibrillation: the Pacemaker Atrial Fibrillation Suppression (PAFS) study.
Sulke N; Silberbauer J; Boodhoo L; Freemantle N; Kamalvand K; O'Nunain S; Hildick-Smith D; Lloyd GW; Patel NR; Paul V
Europace; 2007 Sep; 9(9):790-7. PubMed ID: 17562750
[TBL] [Abstract][Full Text] [Related]
19. Progression of paroxysmal atrial fibrillation to persistent atrial fibrillation in patients with bradyarrhythmias.
Saksena S; Hettrick DA; Koehler JL; Grammatico A; Padeletti L
Am Heart J; 2007 Nov; 154(5):884-92. PubMed ID: 17967594
[TBL] [Abstract][Full Text] [Related]
20. Long-term reduction of atrial tachyarrhythmia recurrences in patients paced for bradycardia-tachycardia syndrome.
Padeletti L; Santini M; Boriani G; Botto G; Gulizia M; Molon G; Luzzi G; Senatore G; Giraldi F; Zolezzi F; Pieragnoli P; Pro F; Desanto T; Grammatico A;
Heart Rhythm; 2005 Oct; 2(10):1047-57. PubMed ID: 16188580
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
